NASDAQ:TVTYTivity Health Stock Price, Forecast & News

Tivity Health's stock was trading at $7.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TVTY shares have increased by 40.8% and is now trading at $11.12. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last year. There are currently 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Tivity Health.

Tivity Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Tivity Health.

Tivity Health Inc (NASDAQ:TVTY) released its quarterly earnings data on Wednesday, May, 6th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.18) by $0.06. The business had revenue of $337.66 million for the quarter, compared to analysts' expectations of $339.52 million. Tivity Health had a positive return on equity of 20.51% and a negative net margin of 38.98%. View Tivity Health's earnings history.

11 Wall Street analysts have issued twelve-month price objectives for Tivity Health's stock. Their forecasts range from $4.00 to $32.00. On average, they anticipate Tivity Health's share price to reach $17.00 in the next twelve months. This suggests a possible upside of 52.9% from the stock's current price. View analysts' price targets for Tivity Health.

Press coverage about TVTY stock has trended somewhat negative on Thursday, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Tivity Health earned a news impact score of -1.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutTivity Health.

Tivity Health saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 13,790,000 shares, an increase of 6.2% from the April 15th total of 12,980,000 shares. Based on an average daily trading volume, of 2,014,500 shares, the short-interest ratio is presently 6.8 days. Currently, 32.8% of the shares of the stock are sold short. View Tivity Health's Current Options Chain.

Some companies that are related to Tivity Health include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include Energy Transfer LP Unit (ET), CBL & Associates Properties (CBL), Canopy Growth (CGC), Netflix (NFLX), Nektar Therapeutics (NKTR), AT&T (T), NVIDIA (NVDA), Applied Materials (AMAT), Cornerstone Total Return Fund (CRF) and salesforce.com (CRM).

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Tivity Health's stock is owned by many different retail and institutional investors. Top institutional investors include Hudson Executive Capital LP (18.06%), BlackRock Inc. (14.92%), State Street Corp (3.74%), Geode Capital Management LLC (1.37%), Bank of New York Mellon Corp (1.17%) and Assenagon Asset Management S.A. (1.00%). Company insiders that own Tivity Health stock include Bradley S Karro, Donato Tramuto, Ira Sochet, Kevin Wills, Lee Shapiro and Sara Finley. View institutional ownership trends for Tivity Health.

TVTY stock was sold by a variety of institutional investors in the last quarter, including Van Berkom & Associates Inc., Wells Fargo & Company MN, Parametric Portfolio Associates LLC, JPMorgan Chase & Co., Deutsche Bank AG, Russell Investments Group Ltd., Alliancebernstein L.P., and BlackRock Inc.. View insider buying and selling activity for Tivity Health.

TVTY stock was bought by a variety of institutional investors in the last quarter, including Hudson Executive Capital LP, Assenagon Asset Management S.A., Two Sigma Advisers LP, State Street Corp, Voce Capital Management LLC, Thoroughbred Financial Services LLC, Two Sigma Investments LP, and Geode Capital Management LLC. Company insiders that have bought Tivity Health stock in the last two years include Bradley S Karro, Ira Sochet, Kevin Wills, Lee Shapiro, and Sara Finley. View insider buying and selling activity for Tivity Health.

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TVTY stock can currently be purchased for approximately $11.12.

Tivity Health has a market capitalization of $539.21 million and generates $1.13 billion in revenue each year. The company earns $-286,820,000.00 in net income (profit) each year or $2.02 on an earnings per share basis. Tivity Health employs 500 workers across the globe.

The official website for Tivity Health is www.tivityhealth.com.

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 800-869-5311 or via email at [email protected]